Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevanac + Pred Forte for cystoid macular edema after cataract surgery
NL-OMON26441Active, not recruiting
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cystoid macular edema (CME) comparing Placebo with Nevanac + Pred Forte (2 arms). Primary endpoints: OCT-proven cystoid macular edema at 12 weeks and Best corrected visual acuity at 12 weeks. Started May 2010; status: active, not recruiting.
02
Drugs
nepafenacprednisolone
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NL-OMON26441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26441.